These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 30361825)
21. A novel long non-coding RNA FGF14-AS2 is correlated with progression and prognosis in breast cancer. Yang F; Liu YH; Dong SY; Ma RM; Bhandari A; Zhang XH; Wang OC Biochem Biophys Res Commun; 2016 Feb; 470(3):479-483. PubMed ID: 26820525 [TBL] [Abstract][Full Text] [Related]
22. MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers. Barwal TS; Sharma U; Bazala S; Singh I; Jain M; Prakash H; Shekhar S; Sandberg EN; Bishayee A; Jain A Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920789 [TBL] [Abstract][Full Text] [Related]
24. Angiogenesis regulation by microRNAs and long non-coding RNAs in human breast cancer. Chong ZX; Yeap SK; Ho WY Pathol Res Pract; 2021 Mar; 219():153326. PubMed ID: 33601152 [TBL] [Abstract][Full Text] [Related]
25. The hypoxia-responsive long non-coding RNAs may impact on the tumor biology and subsequent management of breast cancer. Kapinova A; Kubatka P; Zubor P; Golubnitschaja O; Dankova Z; Uramova S; Pilchova I; Caprnda M; Opatrilova R; Richnavsky J; Kruzliak P; Danko J Biomed Pharmacother; 2018 Mar; 99():51-58. PubMed ID: 29324312 [TBL] [Abstract][Full Text] [Related]
26. Application of Long Noncoding RNAs in Osteosarcoma: Biomarkers and Therapeutic Targets. Li Z; Dou P; Liu T; He S Cell Physiol Biochem; 2017; 42(4):1407-1419. PubMed ID: 28715796 [TBL] [Abstract][Full Text] [Related]
27. Long Noncoding RNAs in Taxane Resistance of Breast Cancer. Chen H; Zhang M; Deng Y Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569629 [TBL] [Abstract][Full Text] [Related]
28. Upregulation of the long noncoding RNAs DSCAM-AS1 and MANCR is a potential diagnostic marker for breast carcinoma. Tahmouresi F; Razmara E; Pakravan K; Mossahebi-Mohammadi M; Rouhollah F; Montazeri M; Sarrafzadeh A; Fahimi H; Babashah S Biotechnol Appl Biochem; 2021 Dec; 68(6):1250-1256. PubMed ID: 33012018 [TBL] [Abstract][Full Text] [Related]
29. Functional Relationships between Long Non-Coding RNAs and Estrogen Receptor Alpha: A New Frontier in Hormone-Responsive Breast Cancer Management. Melone V; Salvati A; Brusco N; Alexandrova E; D'Agostino Y; Palumbo D; Palo L; Terenzi I; Nassa G; Rizzo F; Giurato G; Weisz A; Tarallo R Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674656 [TBL] [Abstract][Full Text] [Related]
30. Advances in Pathophysiology of Triple-Negative Breast Cancer: The Potential of lncRNAs for Clinical Diagnosis, Treatment, and Prognostic Monitoring. Zhou Y; Yue Y; Fan S; Jia Q; Ding X Mol Biotechnol; 2021 Dec; 63(12):1093-1102. PubMed ID: 34245439 [TBL] [Abstract][Full Text] [Related]
31. Biological functions and clinical applications of exosomal long non-coding RNAs in cancer. Wang Y; Zhang M; Zhou F J Cell Mol Med; 2020 Oct; 24(20):11656-11666. PubMed ID: 32924276 [TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNAs engender drug resistance to different subtypes of treatments of breast cancers and may provide a "next generation" therapy option. Chen WT; Wu HT; Shen JX; Ye QQ; Zhang ML; Chen WJ; Liu J Discov Med; 2020; 29(156):27-39. PubMed ID: 32598860 [TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNAs as prognostic markers in human breast cancer. Liu H; Li J; Koirala P; Ding X; Chen B; Wang Y; Wang Z; Wang C; Zhang X; Mo YY Oncotarget; 2016 Apr; 7(15):20584-96. PubMed ID: 26942882 [TBL] [Abstract][Full Text] [Related]
34. Molecular and cellular functions of long non-coding RNAs in prostate and breast cancer. Zhu YS; Zhu J Adv Clin Chem; 2022; 106():91-179. PubMed ID: 35152976 [TBL] [Abstract][Full Text] [Related]
35. Long Non-Coding RNAs: the New Horizon of Gene Regulation in Ovarian Cancer. Worku T; Bhattarai D; Ayers D; Wang K; Wang C; Rehman ZU; Talpur HS; Yang L Cell Physiol Biochem; 2017; 44(3):948-966. PubMed ID: 29179183 [TBL] [Abstract][Full Text] [Related]
36. Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer. Campos-Parra AD; López-Urrutia E; Orozco Moreno LT; López-Camarillo C; Meza-Menchaca T; Figueroa González G; Bustamante Montes LP; Pérez-Plasencia C Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30208633 [TBL] [Abstract][Full Text] [Related]
37. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer. Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110 [TBL] [Abstract][Full Text] [Related]
38. The Clinical Utility of lncRNAs and Their Application as Molecular Biomarkers in Breast Cancer. Arriaga-Canon C; Contreras-Espinosa L; Aguilar-Villanueva S; Bargalló-Rocha E; García-Gordillo JA; Cabrera-Galeana P; Castro-Hernández C; Jiménez-Trejo F; Herrera LA Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108589 [TBL] [Abstract][Full Text] [Related]
39. Exosome-mediated transfer of lncRNA‑SNHG14 promotes trastuzumab chemoresistance in breast cancer. Dong H; Wang W; Chen R; Zhang Y; Zou K; Ye M; He X; Zhang F; Han J Int J Oncol; 2018 Sep; 53(3):1013-1026. PubMed ID: 30015837 [TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications. Niu ZS; Niu XJ; Wang WH World J Gastroenterol; 2017 Aug; 23(32):5860-5874. PubMed ID: 28932078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]